External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma.
about
Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma.Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkers.Serum 20S proteasome is elevated in patients with renal cell carcinoma and associated with poor prognosis.Laparoscopic and open partial nephrectomy: complication comparison using the Clavien system.Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma.Prognostic factors in localized renal cell cancer.MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.Renal cell carcinoma: risk assessment and prognostic factors for newly diagnosed patients.Metastatic renal cell carcinoma risk according to tumor size.Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma.Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.C1-C2 pigmented villonodular synovitis and clear cell carcinoma: unexpected presentation of a rare disease and a review of the literature.EGFR kinase-dependent and kinase-independent roles in clear cell renal cell carcinoma.Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma.Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients.Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer.Appraisal and use of a prognostic study from the urological literature.Can the Kattan nomogram still accurately predict prognosis in renal cell carcinoma using the revised 2010 tumor-nodes-metastasis reclassification?High truncated-O-glycan score predicts adverse clinical outcome in patients with localized clear-cell renal cell carcinoma after surgery.Prognostic factors in renal cell carcinoma: analysis of 227 patients treated at the Brazilian National Cancer Institute.High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma.Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma.Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR studyNomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma
P2860
Q34283721-2157EDC1-AFCB-4FA5-A652-C80D70D786B2Q34354554-1B5174ED-E261-4AF2-997F-E043BA25A0DCQ35540073-5DE1CA0A-0A8D-4307-A6FE-2CAE2E9F9E09Q35835132-B7DFB2A2-8481-49C5-BFE4-9920C5A5711EQ36124543-81B5AAC0-B0F6-4DF6-B299-57930DFFD924Q36287965-F8BBDED3-8319-4959-B77A-23B5B8FC5CF6Q36794758-0F0C9D02-14C8-4EF0-ADEE-EC46B69FBD82Q36797273-857B0823-8A59-4DC4-85FC-153F959C805DQ37321213-E795C5A6-433B-4A94-AAD7-A05A230155C6Q37326113-A2837374-4193-4E9A-A6ED-DBC967FE0759Q37461830-DCEBE730-E3EC-4245-9A7C-C17B9CDE14E2Q37980905-F8A4481A-B227-4FE7-901B-20AE5256618CQ38218470-7A418C4B-8D24-4C55-A00A-D135799FF058Q38554153-CD3DFF79-75C4-449F-AC15-F91F0CE77A5DQ38619018-F74A5639-34B8-4571-8DDD-642299729891Q38861806-F38EE9B9-0AE9-427D-B9F5-57F58F9AED75Q39341646-B0360B49-876C-4647-91DC-0CFAA0E57596Q40568812-74530CE8-7FB6-4BD4-ACAA-814F286E7C4DQ45070769-031F8611-844C-47B3-93B8-BB3B90CB4528Q47119117-953A58BF-54C9-41F8-B6CE-08E7C16EBFE5Q50947445-3BDDD915-C6F5-42D8-88EE-11AB57AA8EECQ51451231-E7C3069A-C2FA-4879-8837-70BB599D8489Q52658572-CDC361FE-7265-4B98-89E2-00B34A4FD621Q57425968-82313017-F894-44FE-BD20-622D7BE68393Q58761514-85F2AD9C-B326-41C1-AEF1-CBC93E6343C6
P2860
External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
External validation of the May ...... entional renal cell carcinoma.
@en
External validation of the May ...... entional renal cell carcinoma.
@nl
type
label
External validation of the May ...... entional renal cell carcinoma.
@en
External validation of the May ...... entional renal cell carcinoma.
@nl
prefLabel
External validation of the May ...... entional renal cell carcinoma.
@en
External validation of the May ...... entional renal cell carcinoma.
@nl
P2093
P1476
External validation of the May ...... entional renal cell carcinoma.
@en
P2093
Christine Lohse
Giacomo Novara
Guido Martignoni
Maurizio Pea
Stefano Cavalleri
Vincenzo Ficarra
Walter Artibani
P304
P356
10.1016/S0022-5347(05)00684-1
P407
P577
2006-04-01T00:00:00Z